ArticleMolecular therapy : the journal of the American Society of Gene Therapy2024

Intranasal vaccination with engineered BCG expressing CCL2 induces a stronger immune barrier against Mycobacterium tuberculosis than BCG.

Shaohua Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.